期刊
JOURNAL OF CLINICAL IMMUNOLOGY
卷 40, 期 5, 页码 671-681出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-020-00790-x
关键词
Immunodeficiency; congenital disorders of glycosylation; Epstein-Barr virus; MAGT1; XMEN disease; lymphoma; carbohydrate deficient transferrin; NKG2D; CD70; CD28; oligosaccharyltransferase complex; magnesium
类别
资金
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- NIH
- Office of Disease Prevention, NIH
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001187] Funding Source: NIH RePORTER
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus (EBV) infection, and neoplasia (XMEN) disease is an inborn error of glycosylation and immunity caused by loss of function mutations in the magnesium transporter 1 (MAGT1) gene. It is a multisystem disease that strongly affects certain immune cells. MAGT1 is now confirmed as a non-catalytic subunit of the oligosaccharyltransferase complex and facilitates Asparagine (N)-linked glycosylation of specific substrates, making XMEN a congenital disorder of glycosylation manifesting as a combined immune deficiency. The clinical disease has variable expressivity, and impaired glycosylation of key MAGT1-dependent glycoproteins in addition to Mg2+ abnormalities can explain some of the immune manifestations. NKG2D, an activating receptor critical for cytotoxic function against EBV, is poorly glycosylated and invariably decreased on CD8(+) T cells and natural killer (NK) cells from XMEN patients. It is the best biomarker of the disease. The characterization of EBV-naive XMEN patients has clarified features of the genetic disease that were previously attributed to EBV infection. Extra-immune manifestations, including hepatic and neurological abnormalities, have recently been reported. EBV-associated lymphomas remain the main cause of severe morbidity. Unfortunately, treatment options to address the underlying mechanism of disease remain limited and Mg2+ supplementation has not proven successful. Here, we review the expanding clinical phenotype and recent advances in glycobiology that have increased our understanding of XMEN disease. We also propose updating XMEN to X-linked MAGT1 deficiency with increased susceptibility to EBV-infection and N-linked glycosylation defect in light of these novel findings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据